165 related articles for article (PubMed ID: 17135986)
1. Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
Kratochvil C; Emslie G; Silva S; McNulty S; Walkup J; Curry J; Reinecke M; Vitiello B; Rohde P; Feeny N; Casat C; Pathak S; Weller E; May D; Mayes T; Robins M; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1412-8. PubMed ID: 17135986
[TBL] [Abstract][Full Text] [Related]
2. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
March J; Silva S; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
[TBL] [Abstract][Full Text] [Related]
3. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
Kennard B; Silva S; Vitiello B; Curry J; Kratochvil C; Simons A; Hughes J; Feeny N; Weller E; Sweeney M; Reinecke M; Pathak S; Ginsburg G; Emslie G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1404-11. PubMed ID: 17135985
[TBL] [Abstract][Full Text] [Related]
4. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.
Kratochvil CJ; May DE; Silva SG; Madaan V; Puumala SE; Curry JF; Walkup J; Kepley H; Vitiello B; March JS
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):519-27. PubMed ID: 19877976
[TBL] [Abstract][Full Text] [Related]
5. Treatment for Adolescents with Depression Study (TADS): safety results.
Emslie G; Kratochvil C; Vitiello B; Silva S; Mayes T; McNulty S; Weller E; Waslick B; Casat C; Walkup J; Pathak S; Rohde P; Posner K; March J; ;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1440-55. PubMed ID: 17135989
[TBL] [Abstract][Full Text] [Related]
6. Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study.
Scott K; Lewis CC; Marti CN
J Am Acad Child Adolesc Psychiatry; 2019 Mar; 58(3):319-328. PubMed ID: 30768414
[TBL] [Abstract][Full Text] [Related]
7. Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.
Rohde P; Silva SG; Tonev ST; Kennard BD; Vitiello B; Kratochvil CJ; Reinecke MA; Curry JF; Simons AD; March JS
Arch Gen Psychiatry; 2008 Apr; 65(4):447-55. PubMed ID: 18391133
[TBL] [Abstract][Full Text] [Related]
8. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
Vitiello B; Rohde P; Silva S; Wells K; Casat C; Waslick B; Simons A; Reinecke M; Weller E; Kratochvil C; Walkup J; Pathak S; Robins M; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1419-26. PubMed ID: 17135987
[TBL] [Abstract][Full Text] [Related]
9. Estimating patient-specific treatment advantages in the 'Treatment for Adolescents with Depression Study'.
Foster S; Mohler-Kuo M; Tay L; Hothorn T; Seibold H
J Psychiatr Res; 2019 May; 112():61-70. PubMed ID: 30856378
[TBL] [Abstract][Full Text] [Related]
10. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
[TBL] [Abstract][Full Text] [Related]
11. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).
Lewis CC; Simons AD; Nguyen LJ; Murakami JL; Reid MW; Silva SG; March JS
J Am Acad Child Adolesc Psychiatry; 2010 Feb; 49(2):132-40. PubMed ID: 20215935
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
[TBL] [Abstract][Full Text] [Related]
13. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
15. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
Bondar J; Caye A; Chekroud AM; Kieling C
Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
[TBL] [Abstract][Full Text] [Related]
16. Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).
Vitiello B; Kratochvil CJ; Silva S; Curry J; Reinecke M; Pathak S; Waslick B; Hughes CW; Prentice ED; May DE; March JS
J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1642-50. PubMed ID: 18030086
[TBL] [Abstract][Full Text] [Related]
17. Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy?
Vitiello B
CNS Drugs; 2009; 23(4):271-80. PubMed ID: 19374457
[TBL] [Abstract][Full Text] [Related]
18. Moderators and Predictors of Response After 36 Weeks of Treatment in the Treatment for Adolescents with Depression Study (TADS).
O'Dor SL; Washburn J; Howard KR; Reinecke MA
Res Child Adolesc Psychopathol; 2021 Nov; 49(11):1489-1501. PubMed ID: 34050856
[TBL] [Abstract][Full Text] [Related]
19. Onset of alcohol or substance use disorders following treatment for adolescent depression.
Curry J; Silva S; Rohde P; Ginsburg G; Kennard B; Kratochvil C; Simons A; Kirchner J; May D; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
J Consult Clin Psychol; 2012 Apr; 80(2):299-312. PubMed ID: 22250853
[TBL] [Abstract][Full Text] [Related]
20. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
